Overview
Use this article to understand why you may still experience hunger during weight-loss treatment, particularly during the initial dose titration phase, and how dietary adjustments support treatment effectiveness.
Expecting appetite changes during dose titration
Feeling hungry during the early stages of weight-loss treatment is common and expected.
Gradual dose escalation: Treatment begins at a low starting dose to allow your body time to adapt to the medication and to minimise potential gastrointestinal side effects.
Progressive appetite effects: As your dose is gradually increased over time according to the recommended treatment schedule, appetite suppression typically becomes more noticeable.
Individual response: Everyone responds to weight-loss treatments differently. Medication supports appetite regulation, but it does not completely eliminate hunger for every individual at a specific dose level.
Supporting weight-loss treatment with lifestyle changes
Injectable weight-loss medications are designed to complement, rather than replace, healthy lifestyle habits.
Nutrient-dense food choices: Incorporating whole, unprocessed foods into your diet helps maintain stable blood sugar levels and promotes satiety.
Balanced dietary components: Prioritising lean proteins, healthy fats, and fiber-rich complex carbohydrates enhances the natural appetite-regulating effects of GIP/GLP-1 medications.
Long-term habits: Combining treatment with balanced nutrition and regular physical activity ensures more sustainable long-term weight management results.
Additional Assistance
If you still need help after reviewing the information above, additional assistance is available.